# Fyteko

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/fyteko

- Industry: Biotechnology
- Headquarters: Brussels, Belgium
- Website: www.fyteko.com/
- Total disclosed funding: $10M
- Latest round: Series B (Jan 16, 2025)
- Investors on record: 6

## About

Fyteko is a biotechnology company specializing in innovative biopesticide solutions that enhance agricultural crop resilience and yield amidst environmental challenges.Fyteko, founded in 2014 in Brussels, Belgium, focuses on developing biopesticide solutions. The company has undergone strategic refinement to enhance its operational focus. Founded by experts in agricultural biotechnology, Fyteko has one significant global office located in Brussels. The company recently completed a Series B funding round on February 12, 2025, raising EUR 13.000 mn led by Crédit Mutuel Capital Privé along with other investors including EIT Food and others. This funding raised coincides with the total amount of EUR 13.000 mn raised to date.Fyteko specializes in innovative biopesticide solutions designed to enhance crop yield and resilience against abiotic stresses such as drought, flooding, and temperature fluctuations. Their core product offerings include NURSEED and NURSPRAY, which contain novel bio-based active ingredients derived from plant cell walls. These products act as biostimulants, priming crops to better cope with environmental challenges, thereby helping farmers maintain and improve yields in a changing climate. Fyteko's products have received regulatory approval for use in the European Union, the United States, and various African markets, catering primarily to agricultural producers seeking sustainable solutions that align with modern farming practices.Fyteko generates revenue through the sale of its biostimulant products, operating on a B2B model that targets agricultural businesses and farmers directly. The company engages in transactional relationships with clients, where orders for NURSEED and NURSPRAY are processed as individual sales or through ongoing partnerships. This structure may involve bulk purchasing agreements, allowing clients to acquire significant quantities of the products to meet their agricultural needs. By focusing on flagship products that enhance crop resilience and yield, Fyteko capitalizes on the growing demand for sustainable agricultural solutions in its target markets.Fyteko plans to utilize the EUR 13.000 mn raised in its Series B funding to further develop its product offerings. The company aims to design and launch new innovative biopesticide products, with specific release dates to be announced. Additionally, Fyteko is targeting expansion into new markets, including the United States and select African regions, with the goal of establishing a significant presence in these areas by 2026. Recent funding will support these initiatives, facilitating product development and market entry strategies.

## Funding rounds

- Series B, Jan 16, 2025, $10M — Finance&invest.brussels, Invest Mons-Borinage-Centre, Credit Mutuel Capital Prive, Supernova, Federal Holding and Investment Company, EIT Food

## Investors

- Finance&invest.brussels — Series B
- Invest Mons-Borinage-Centre (https://capitalatlas.ai/funds/invest-mons-borinage-centre) — Series B
- Credit Mutuel Capital Prive — Series B
- Supernova — Series B
- Federal Holding and Investment Company (https://capitalatlas.ai/funds/federal-holding-and-investment-company) — Series B
- EIT Food — Series B